Ulland Investment Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$808K Buy
18,934
+6,045
+47% +$328K 0.6% 35
2026
Q1
$809K Buy
12,889
+135
+1% +$10.8K 0.69% 31
2025
Q4
$1.22M Sell
12,754
-220
-2% -$21.6K 0.97% 25
2025
Q3
$1.27M Hold
12,974
0.95% 24
2025
Q2
$1.39M Sell
12,974
-1,625
-11% -$164K 1.06% 22
2025
Q1
$1.47M Sell
14,599
-920
-6% -$92.6K 1.23% 22
2024
Q4
$1.39M Sell
15,519
-420
-3% -$37K 0.88% 22
2024
Q3
$1.34M Hold
15,939
0.98% 22
2024
Q2
$1.23M Hold
15,939
0.85% 26
2024
Q1
$1.09M Sell
15,939
-110
-0.7% -$7.07K 0.87% 26
2023
Q4
$928K Sell
16,049
-175
-1% -$9.34K 0.94% 23
2023
Q3
$857K Sell
16,224
-27
-0.2% -$1.42K 0.94% 27
2023
Q2
$879K Hold
16,251
0.9% 27
2023
Q1
$813K Sell
16,251
-1,750
-10% -$82.5K 0.96% 27
2022
Q4
$833K Sell
18,001
-2,665
-13% -$115K 1% 28
2022
Q3
$800K Buy
20,666
+27
+0.1% +$1.08K 0.87% 30
2022
Q2
$769K Sell
20,639
-10,435
-34% -$425K 0.79% 34
2022
Q1
$1.38M Sell
31,074
-750
-2% -$32.5K 1.03% 27
2021
Q4
$1.35M Buy
+31,824
New +$1.34M 0.86% 28

Other funds holding BSX

Ulland Investment Advisors's BSX Position: Q2 2026 in Review

Ulland Investment Advisors increased its Boston Scientific (BSX) stake by 47% in Q2 2026, buying an estimated $328K and bringing the position to 18,934 shares worth $808K. The position accounts for 0.6% of the portfolio, ranked #35.

Ulland Investment Advisors first reported a position in BSX in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.47M in Q1 2025. 665 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Ulland Investment Advisors held 18,934 shares of Boston Scientific worth $808K as of Q2 2026.
  • Ulland Investment Advisors bought 6,045 Boston Scientific shares in Q2 2026, an estimated $328K.
  • Boston Scientific made up 0.6% of Ulland Investment Advisors's portfolio in Q2 2026, its #35 holding.
  • Ulland Investment Advisors first reported a position in Boston Scientific in Q4 2021 and has held it in 19 quarters since.
  • Ulland Investment Advisors's Boston Scientific position peaked at $1.47M in Q1 2025.
  • 665 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Ulland Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.